Stoke Therapeutics, Inc. (STOK)

29.65 +0.62 (+2.14%) USD  |  NASDAQ  |  May 19, 14:23
More

Stoke Therapeutics EBITDA Margin (TTM)

EBITDA Margin (TTM) Chart

View EBITDA Margin (TTM) for STOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin (TTM) Range, Past 5 Years

View EBITDA Margin (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (TTM) Benchmarks

View EBITDA Margin (TTM) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Scholar Rock Holding Corp. --
Vertex Pharmaceuticals, Inc. Upgrade
Zymeworks, Inc. Upgrade